Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

One-month Latent Tuberculosis Treatment for Renal Transplant Candidates

NCT05411744 is registered in ClinicalTrials.gov with Rutgers, The State University of New Jersey as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05411744 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
One-month Latent Tuberculosis Treatment for Renal Transplant Candidates
Lead sponsor
Rutgers, The State University of New Jersey
Phase
Phase 4
Overall status
Active, not recruiting
Start date
July 1, 2022
Completion date
June 30, 2029
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease, latent tuberculosis, renal transplant candidate for left kidney, renal transplant candidate for right kidney